Inventor
SCHLAKE THOMAS
DE33 patents
⚠️ This page may combine multiple inventors who share the name “SCHLAKE THOMAS”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
CUREVAC AG
18 patentsUS10912826B2Feb 9, 2021
Nucleic acid comprising or coding for a histone stem-loop and a poly(A) sequence or a polyadenylation signal for increasing the expression of an encoded pathogenic antigen
CUREVAC AG45 citations98
US10799577B2Oct 13, 2020
Nucleic acid comprising or coding for a histone stem-loop and a poly(A) sequence or a polyadenylation signal for increasing the expression of an encoded pathogenic antigen
CUREVAC AG28 citations98
US10682406B2Jun 16, 2020
Nucleic acid comprising or coding for a histone stem-loop and a poly(A) sequence or a polyadenylation signal for increasing the expression of an encoded pathogenic antigen
CUREVAC AG29 citations98
US10166283B2Jan 1, 2019
Nucleic acid comprising or coding for a histone stem-loop and a poly(A) sequence or a polyadenylation signal for increasing the expression of an encoded pathogenic antigen
CUREVAC AG37 citations98
US10111968B2Oct 30, 2018
Nucleic acid comprising or coding for a histone stem-loop and a poly(A) sequence or a polyadenylation signal for increasing the expression of an encoded therapeutic protein
CUREVAC AG39 citations98
US9907862B2Mar 6, 2018
Disulfide-linked polyethyleneglycol/peptide conjugates for the transfection of nucleic acids
CUREVAC AG35 citations98
US9839697B2Dec 12, 2017
Nucleic acid comprising or coding for a histone stem-loop and a poly(a) sequence or a polyadenylation signal for increasing the expression of an encoded protein
CUREVAC AG39 citations98
US11149278B2Oct 19, 2021
Artificial nucleic acid molecules for improved protein expression
CUREVAC AG31 citations97
US11110156B2Sep 7, 2021
Nucleic acid comprising or coding for a histone stem-loop and a poly(a) sequence or a polyadenylation signal for increasing the expression of an encoded tumour antigen
CUREVAC AG28 citations94
US10898589B2Jan 26, 2021
Nucleic acid comprising or coding for a histone stem-loop and a poly(A) sequence or a polyadenylation signal for increasing the expression of an encoded therapeutic protein
CUREVAC AG28 citations94
US10898584B2Jan 26, 2021
Modified RNA with decreased immunostimulatory properties
CUREVAC AG30 citations94
US10751424B2Aug 25, 2020
Disulfide-linked polyethyleneglycol/peptide conjugates for the transfection of nucleic acids
CUREVAC AG29 citations94
US10653799B2May 19, 2020
Nucleic acid comprising or coding for a histone stem-loop and a poly(A) sequence or a polyadenylation signal for increasing the expression of an encoded protein
CUREVAC AG28 citations94
US10610605B2Apr 7, 2020
Nucleic acid comprising or coding for a histone stem-loop and a poly(A) sequence or a polyadenylation signal for increasing the expression of an encoded therapeutic protein
CUREVAC AG28 citations94
US10232024B2Mar 19, 2019
Nucleic acid comprising or coding for a histone stem-loop and a poly(A) sequence or a polyadenylation signal for increasing the expression of an encoded allergenic antigen or an autoimmune self-antigen
CUREVAC AG32 citations94
US10010592B2Jul 3, 2018
Nucleic acid comprising or coding for a histone stem-loop and a poly(A) sequence or a polyadenylation signal for increasing the expression of an encoded tumour antigen
CUREVAC AG36 citations94
US11345920B2May 31, 2022
Artificial nucleic acid molecules for improved protein expression
CUREVAC AG17 citations93
US11286492B2Mar 29, 2022
Artificial nucleic acid molecules for improved protein expression
CUREVAC AG22 citations93
CureVac SE
9 patentsUS11761009B2Sep 19, 2023
Artificial nucleic acid molecules for improved protein expression
CureVac SE5 citations85
US11739335B2Aug 29, 2023
Nucleic acids encoding CRISPR-associated proteins and uses thereof
CureVac SE7 citations80
US12442005B2Oct 14, 2025
Artificial nucleic acid molecules for improved protein expression
CureVac SE1 citations74
US12109275B2Oct 8, 2024
Nucleic acid comprising or coding for a histone stem-loop and a poly(A) sequence or a polyadenylation signal for increasing the expression of an encoded protein
CureVac SE1 citations73
US11697816B2Jul 11, 2023
Artificial nucleic acid molecules
CureVac SE5 citations73
US12533422B2Jan 27, 2026
Modified RNA with decreased immunostimulatory properties
CureVac SE0 citations63
US12201680B2Jan 21, 2025
Nucleic acid comprising or coding for a histone stem-loop and a poly(A) sequence or a polyadenylation signal for increasing the expression of an encoded pathogenic antigen
CureVac SE0 citations63
US12258567B2Mar 25, 2025
Artificial nucleic acid molecules
CureVac SE0 citations61
US12371699B2Jul 29, 2025
Nucleic acids encoding CRISPR-associated proteins and uses thereof
CureVac SE0 citations57
CUREVAC GMBH
3 patentsUS9669089B2Jun 6, 2017
Nucleic acid comprising or coding for a histone stem-loop and a poly(A) sequence or a polyadenylation signal for increasing the expression of an encoded pathogenic antigen
CUREVAC GMBH107 citations99
US9447431B2Sep 20, 2016
Nucleic acid comprising or coding for a histone stem-loop and a poly(A) sequence or a polyadenylation signal for increasing the expression of an encoded therapeutic protein
CUREVAC GMBH70 citations98
US9314535B2Apr 19, 2016
Disulfide-linked polyethyleneglycol/peptide conjugates for the transfection of nucleic acids
CUREVAC GMBH32 citations94